4.3 Review

Lipoic acid and lipoic acid analogs in cancer metabolism and chemotherapy

Journal

EXPERT REVIEW OF CLINICAL PHARMACOLOGY
Volume 7, Issue 6, Pages 837-846

Publisher

INFORMA HEALTHCARE
DOI: 10.1586/17512433.2014.966816

Keywords

cancer metabolism; chemotherapy; lipoate; lipoate analogs; lipoic acid; lipoic acid analogs; tumor mitochondria; two compartment metabolism

Funding

  1. Cornerstone Pharmaceuticals
  2. Cornerstone Pharmaceuticals, Inc.

Ask authors/readers for more resources

The lipoic acid (lipoate) coenzyme is unique in all of mammalian metabolism. It is not only crucial to the function of some of the major enzymes feeding carbon into the tricarboxylic acid cycle, but also generates dynamic regulatory information about the metabolic status of the mitochondrial matrix, ultimately functioning to control these metabolic fluxes. Moreover, these lipoate-sensitive regulatory processes are apparently systematically redesigned in tumor cells and the affected enzymes commonly become especially central to cancer metabolism. Thus, lipoate-sensitive regulatory processes constitute potentially uniquely valuable targets for chemotherapeutic attack. Our goal here is to review the current status of our knowledge relevant to the use of lipoate and lipoate analogs to therapeutically attack malignant disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available